Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT02845440 Completed - Schizophrenia Clinical Trials

Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness

Start date: July 14, 2016
Phase: N/A
Study type: Interventional

The overall aim of this study is to test the effect of academic detailing (i.e. provider-level educational intervention focused on evidence-based smoking cessation treatment for those with psychiatric illness) and community health worker (CHW) support on the provision and utilization of standard of care smoking cessation treatment to those with serious mental illness (SMI) and smoking cessation rates for adults with SMI who smoke.

NCT ID: NCT02836405 Completed - Clinical trials for Autism Spectrum Disorder

TMS for the Investigation of Brain Plasticity in Autism Spectrum Disorders

Start date: May 2015
Phase:
Study type: Observational

The main purpose is to study brain plasticity (the changes that occur in the brain through experience) in individuals with autism spectrum disorder (ASD). Research suggests that during development, the brains of individuals with ASD may change in response to their experiences differently than the brains of typically developing individuals. Investigators want to understand why and how this difference may contribute to the symptoms of ASD.

NCT ID: NCT02834299 Completed - Clinical trials for Binge Eating Disorder

Dialectical Behavior Therapy Guided Self-Help for Binge Eating Disorder

DBT-GSH-BED
Start date: September 20, 2016
Phase: N/A
Study type: Interventional

This study will compare unguided and guided dialectical behavior therapy (DBT) self-help to an attention-placebo self-help control condition. Participants with binge eating disorder will be randomly assigned to one of the three self-help conditions for 12 weeks. Six guided self-help sessions will take place via secure video-calling. Assessments will take place before, mid-way through, and after the self-help program as well as at 3-month follow-up. Six guided self-help sessions will take place via secure video-calling.

NCT ID: NCT02831699 Completed - Dengue Clinical Trials

The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico

Zik01
Start date: June 21, 2016
Phase:
Study type: Observational

This study will evaluate subjects with fever and/or rash to determine the percentage of those infected by the Zika, Chikungunya, or Dengue virus. The study will also compare the clinical signs, symptoms, and lab abnormalities related to each virus, to better specify each virus's characteristics.

NCT ID: NCT02829970 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

Helping College Students With ADHD Lead Healthier Lifestyles

Start date: September 2015
Phase: N/A
Study type: Interventional

There are currently no published randomized controlled studies examining psychosocial interventions for college students with ADHD, and none specifically targeting AUDs in this population at any age, despite the clear indication from emerging research of the need for such interventions. In the current study, the investigators will develop BA-based treatment intended to increase involvement in healthy, goal-directed activities (e.g., academic, recreational or social activities) and to reduce problematic drinking behaviors and other risk behaviors (e.g., unsafe sex) among college students with ADHD (Behavioral Activation for Attention & Alcohol Disorders; BAAAD). Finalized treatment manuals, altered based on focus group feedback, will be tested in a stage I randomized controlled trial (RCT) among 80 college students randomized to BMI + BAAAD or BMI + supportive counseling (SC). The investigators expect that BMI + BAAAD will be successful with college students with ADHD, in terms of decreasing the escalation of problematic alcohol use behaviors, as compared to BMI + SC. This treatment development study will set the stage for larger-scale RCTs.

NCT ID: NCT02829658 Completed - Clinical trials for Borderline Personality Disorder

Use of Care Services by Patients With Borderline Personality Disorder

EpiB
Start date: February 2009
Phase: N/A
Study type: Observational

Borderline personality disorder (BPD) is characterized by a pervasive pattern of instability and impulsivity. Several North American prospective studies support the high level of mental health care utilization in this population. There is little data in other systems of health organization, such as France. Furthermore, little is known on the variables associated with the mental health service utilization among BPD patients. The main objective was to compare the utilization of mental health care among BPD patients, to the general population and patients with another personality disorder (PD) and to describe the demographic and clinical factors associated with the group of patients who use the most health care.

NCT ID: NCT02828813 Completed - Cognition Disorders Clinical Trials

Neural Mechanisms of Motor and Cognitive Networks

Start date: June 2016
Phase:
Study type: Observational

This study investigates the neural mechanisms of motor and cognitive networks using cognitive assessment, reaction time measurement, high-density EEG and fMRI.

NCT ID: NCT02825927 Completed - Quality of Life Clinical Trials

Swallowing Function, Oral Health, and Food Intake in Old Age

SOFIA
Start date: October 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a specific rehabilitation program with oral screen used in an elderly population with dysphagia can improve elderly's swallowing capacity.

NCT ID: NCT02825732 Completed - Clinical trials for Neurocognitive Disorders

MEMORA-Caregiver : Risk Factors of Caregiver Burden Among Patients With Neurocognitive Disorders or Subjective Cognitive Complaint

MEMORA
Start date: November 2011
Phase: N/A
Study type: Observational

The investigators will investigate which patients' characteristics are associated with caregivers burden and its evolution for outpatients visiting a memory clinic, in particular how functional autonomy, behavioral and psychological symptoms as well as patients comorbidities can influence caregiver burden. The study will be conducted among outpatients with progressive cognitive complaint followed in a Memory Clinic and their primary caregiver. The investigators hypothesis that caregivers experience a higher burden due to disease symptoms such as impairment of functional autonomy, behavioral and cognitive impairment, whatever the aetiology of the cognitive decline.

NCT ID: NCT02824341 Completed - Parkinson's Disease Clinical Trials

Exploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior Disorder

MP-TCSP-IRMf
Start date: October 2015
Phase: N/A
Study type: Interventional

Up to 60% of Parkinson's Disease (PD) patients suffer from REM sleep behavior disorder (RBD), a parasomnia. This disorder is thought to be related to a dysfunction of limbic system and brainstem. Impulse control disorders (ICD) are found in about 14% of PD patients taking dopaminergic drugs. These disorders are thought to be related to a dysfunction of meso-cortico-limbic pathways which belong to the so-called "reward system". A strong link was found between these two disorders and therefore the investigators believe that RBD is associated with impaired reward system. The main objective of this study is to evaluate differences in brain activation between PD patients with and without RBD. The investigators hypothesize that PD patients with RBD have a more severe dysfunction of the reward system (hypoactivation of the meso-cortico-limbic pathway) than patients without RBD, explaining their susceptibility to ICD when exposed to high doses of dopaminergic treatment.